Nuvisan Pharma Services GmbH
Nuvisan Pharma Services GmbH, a leading contract research organisation (CRO), is headquartered in Germany and operates extensively across Europe. Founded in 2016, the company has quickly established itself in the pharmaceutical and biotechnology sectors, providing comprehensive drug development services. Nuvisan offers a unique blend of preclinical and clinical research services, including bioanalytical testing, clinical trial management, and regulatory support. Their commitment to innovation and quality has positioned them as a trusted partner for clients seeking to navigate the complexities of drug development. With a focus on delivering tailored solutions, Nuvisan has achieved significant milestones, enhancing its reputation in the industry. The company continues to expand its capabilities, ensuring it remains at the forefront of pharmaceutical services in a competitive market.
DitchCarbon Score
How does Nuvisan Pharma Services GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nuvisan Pharma Services GmbH's score of 5 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nuvisan Pharma Services GmbH's reported carbon emissions
In 2020, Nuvisan Pharma Services GmbH reported total carbon emissions of approximately 8,860,000 kg CO2e from Scope 3, which includes emissions from purchased goods and services. Their Scope 1 emissions were about 2,010,000 kg CO2e, while Scope 2 emissions totalled approximately 1,570,000 kg CO2e. Comparatively, in 2019, the company recorded Scope 1 emissions of around 2,080,000 kg CO2e, Scope 2 emissions of about 1,680,000 kg CO2e, and Scope 3 emissions of approximately 10,050,000 kg CO2e. This indicates a slight reduction in Scope 1 and Scope 2 emissions from 2019 to 2020, while Scope 3 emissions also decreased. Despite these figures, Nuvisan has not publicly committed to specific reduction targets or initiatives, nor have they joined any formal climate pledges. The company operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction, yet their current commitments remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | |
|---|---|---|
| Scope 1 | 2,080,000 | 0,000,000 |
| Scope 2 | 1,680,000 | 0,000,000 |
| Scope 3 | 10,050,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nuvisan Pharma Services GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
